← Back to Search

Treatment for Chronic Obstructive Pulmonary Disease (SOURCE Trial)

N/A
Recruiting
Led By Fernando J Martinez, MD, MS
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up year 2-5
Awards & highlights

Summary

This is an observational study of 1000 participants to further define the nature of early chronic obstructive pulmonary disease (COPD) in younger, at-risk individuals. The study has three main goals: * To use CT scan imaging to identify which smokers will develop COPD. * To identify biomarkers predictive of smokers that will develop COPD. * To determine if sputum (phlegm) can be analyzed to predict which smokers will develop COPD. Procedures (methods): All participants will undergo study related questionnaires assessing medical history, smoke exposure and use, medication use, social and behavioral health, pulmonary symptoms, food frequency, and will provide nasal swab, blood, stool, and urine samples, pulmonary function testing to determine function, sputum induction to provide a sputum sample for airway biospecimen analysis, and CT imaging of the lungs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~year 2-5
This trial's timeline: 3 weeks for screening, Varies for treatment, and year 2-5 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
PRM fSAD

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityOTHER
2,307 Previous Clinical Trials
14,860,909 Total Patients Enrolled
University of MichiganOTHER
1,833 Previous Clinical Trials
6,422,128 Total Patients Enrolled
University of California, Los AngelesOTHER
1,554 Previous Clinical Trials
10,263,114 Total Patients Enrolled
~77 spots leftby Jan 2025